These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 10998759

  • 1. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
    Ogawa A, Yoshida A, Kanda T, Sugihara S, Suzuki T, Tamura J, Kobayashi I, Nakazato Y.
    J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759
    [Abstract] [Full Text] [Related]

  • 2. [Clinical study of tumor markers in prostatic cancer].
    Ishihara Y, Fukagai T, Ohta K, Hiromoto Y, Hiramori M, Torii T, Higaki Y, Imamura K.
    Hinyokika Kiyo; 1990 Apr; 36(4):425-31. PubMed ID: 1696063
    [Abstract] [Full Text] [Related]

  • 3. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
    Morote Robles J, de Torres Mateos JA.
    Arch Esp Urol; 1989 Apr; 42 Suppl 2():124-30. PubMed ID: 2484148
    [Abstract] [Full Text] [Related]

  • 4. [Recrudescence of prostate cancer with low serum level of PSA and high serum level of CEA and CA19-9: a case report].
    Yokoyama S, Fukuhara S, Imazu T, Hara T, Yamaguchi S, Adachi S.
    Hinyokika Kiyo; 2007 Jul; 53(7):485-7. PubMed ID: 17702183
    [Abstract] [Full Text] [Related]

  • 5. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
    Akimoto S, Akakura K, Shimazaki J.
    Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
    [Abstract] [Full Text] [Related]

  • 6. Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions.
    Tarle M.
    Anticancer Res; 1988 Aug; 8(4):569-72. PubMed ID: 2460018
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
    Pagani F, Zambolin T, Bonora R, Panteghini M.
    J Nucl Med Allied Sci; 1990 Aug; 34(4 Suppl):85-7. PubMed ID: 1709211
    [Abstract] [Full Text] [Related]

  • 8. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
    Sakai N, Ogawa T, Ishibashi Y, Fukuoka H, Sakanishi S.
    Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
    [Abstract] [Full Text] [Related]

  • 9. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
    Tarle M.
    Anticancer Res; 1993 Jun; 13(3):769-77. PubMed ID: 7686362
    [Abstract] [Full Text] [Related]

  • 10. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein].
    Shinoda I.
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov 20; 25(11):2627-39. PubMed ID: 1703555
    [Abstract] [Full Text] [Related]

  • 11. Prostate specific antigen and prostatic acid phosphatase measurements for the follow-up of patients with prostate cancer.
    Mortarelli EA.
    Ann Clin Lab Sci; 1992 Nov 20; 22(4):201-6. PubMed ID: 1380223
    [Abstract] [Full Text] [Related]

  • 12. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A, Simşek F, Ilker Y, Türkeri L, Ercan H.
    Int Urol Nephrol; 1993 Nov 20; 25(3):271-8. PubMed ID: 7693607
    [Abstract] [Full Text] [Related]

  • 13. [Tumor markers in prostate cancer].
    Kuriyama M.
    Gan To Kagaku Ryoho; 1994 Sep 20; 21(12):1915-22. PubMed ID: 7521999
    [Abstract] [Full Text] [Related]

  • 14. [Value of serum PSA and PAP measurement with newly developed latex turbidimetric immunoassay].
    Akino H, Tsuka H, Okada K, Tsuchiya Y, Matsubara M, Arimura K.
    Hinyokika Kiyo; 1995 Jun 20; 41(6):439-45. PubMed ID: 7544063
    [Abstract] [Full Text] [Related]

  • 15. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
    Watanabe M, Kitamura Y, Komatsubara S, Sakata Y.
    Hinyokika Kiyo; 1988 Dec 20; 34(12):2135-41. PubMed ID: 2467542
    [Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma].
    Sugimura Y, Sakurai M, Hioki T, Hayashi N, Yamakawa K, Tajima K, Tochigi H, Kawamura J.
    Hinyokika Kiyo; 1988 Dec 20; 34(12):2129-34. PubMed ID: 2467541
    [Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
    Arai Y, Yoshki T, Okada K, Yoshida O, Yamamoto N, Sakatoku J, Sugimura Y, Kawamura J.
    Hinyokika Kiyo; 1989 Sep 20; 35(9):1519-28. PubMed ID: 2479237
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of prostate-specific antigen as a marker for adenocarcinoma of the prostate.
    Barak M, Mecz Y, Lurie A, Gruener N.
    J Lab Clin Med; 1989 May 20; 113(5):598-603. PubMed ID: 2469756
    [Abstract] [Full Text] [Related]

  • 19. Prostate-specific antigen/prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer.
    Saito T, Hara N, Kitamura Y, Komatsubara S.
    Urology; 2007 Oct 20; 70(4):702-5. PubMed ID: 17991541
    [Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer].
    Park YC, Kiwamoto H, Nishioka T, Tsujihashi H, Mitsubayashi S, Matsuura T, Akiyama T, Kurita T, Miyamoto T.
    Hinyokika Kiyo; 1987 Jun 20; 33(6):883-8. PubMed ID: 2445188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.